1. Home
  2. NOTV vs BNGO Comparison

NOTV vs BNGO Comparison

Compare NOTV & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.34

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.12

Market Cap

11.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
BNGO
Founded
1974
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.7M
11.6M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
NOTV
BNGO
Price
$0.34
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.50
$6.33
AVG Volume (30 Days)
549.0K
98.5K
Earning Date
05-14-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
49.64
N/A
EPS
N/A
N/A
Revenue
$547,656,000.00
$12,000,735.00
Revenue This Year
$5.28
N/A
Revenue Next Year
$5.42
$24.27
P/E Ratio
N/A
N/A
Revenue Growth
511.19
26.26
52 Week Low
$0.25
$1.06
52 Week High
$3.35
$5.50

Technical Indicators

Market Signals
Indicator
NOTV
BNGO
Relative Strength Index (RSI) 45.38 38.12
Support Level $0.26 $1.06
Resistance Level $0.65 $1.18
Average True Range (ATR) 0.05 0.04
MACD 0.02 0.01
Stochastic Oscillator 38.75 29.70

Price Performance

Historical Comparison
NOTV
BNGO

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: